Bolt Biotherapeutics Inc

Company Snapshot
900 Chesapeake Drive
Redwood, CA 94063
United States
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 94
https://www.boltbio.com
Please select from the dropdown
Company Financials

2020
2021
2022
Gross Profit
Operating Income
($49,182,000)
($92,788,000)
($90,321,000)
Net Income
($60,728,000)
($98,591,000)
($88,098,000)
2020
Gross Profit
Operating Income
($49,182,000)
Net Income
($60,728,000)
2021
Gross Profit
Operating Income
($92,788,000)
Net Income
($98,591,000)
2022
Gross Profit
Operating Income
($90,321,000)
Net Income
($88,098,000)
The above data on Bolt Biotherapeutics Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Randall Schatzman
Chief Executive Officer and Director
$817,945
$1,406,097
$11,370
$2,235,412
Randall Schatzman
$2,235,412
Chief Executive Officer and Director
Edith Perez
Chief Medical Officer
$641,050
$468,699
$27,270
$1,137,019
Edith Perez
$1,137,019
Chief Medical Officer
William Quinn
Chief Financial Officer and Principal Accounting Officer
$583,430
$468,699
$11,130
$1,063,259
William Quinn
$1,063,259
Chief Financial Officer and Principal Accounting Officer
Grant Yonehiro
Chief Business Officer
$533,577
$424,061
$11,130
$968,768
Grant Yonehiro
$968,768
Chief Business Officer
Brian O'Callaghan
Independent Director
$52,500
$116,151
$0
$168,651
Brian O'Callaghan
$168,651
Independent Director
Bolt Biotherapeutics Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2022. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us